Allstocks.com's Bulletin Board: Post A Reply

Post A Reply
my profile login | register | search | faq | forum home

»	Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » ProtoKinetix Releases Third in a Series of Scientific Update Videos » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon:
Message: HTML is not enabled. UBB Code™ is enabled.	[QUOTE]Originally posted by jackbequick: [QB] ProtoKinetix Releases Third in a Series of Scientific Update Videos Marietta Ohio, February 26, 2019 ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) announces the launch of the third in a series of informational videos by the Principal Investigators in each field currently being tested. The third video is an update on the testing in the University of British Columbia. UBC will be testing AAGP™ ability to enhance the recover from storage as well as the survival and efficacy of engraftment of hematopoietic stem cells, a technical hurdle in cell-based therapies for bone marrow transplantation and cancer therapy. The goal will be to determine whether AAGP™ enhances the ex vivo survival and maintenance of these valuable stem cells. The study is being conducted under the direction of principal investigator Dr. Kelly McNagny, Professor, Faculty of Medicine, Department of Medical Genetics. Dr. Kelly McNagny Video ...http://protokinetix.com/videos/ Dr. Kelly McNagny Bio [/QB][/QUOTE]

Instant Graemlins	Instant UBB Code™
	What is UBB Code™?

Options

Disable Graemlins in this post.

T O P I C R E V I E W

jackbequick

posted

ProtoKinetix Releases Third in a Series of Scientific Update Videos
Marietta Ohio, February 26, 2019

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) announces the launch of the third in a series of informational videos by the Principal Investigators in each field currently being tested.

The third video is an update on the testing in the University of British Columbia. UBC will be testing AAGP™ ability to enhance the recover from storage as well as the survival and efficacy of engraftment of hematopoietic stem cells, a technical hurdle in cell-based therapies for bone marrow transplantation and cancer therapy.

The goal will be to determine whether AAGP™ enhances the ex vivo survival and maintenance of these valuable stem cells. The study is being conducted under the direction of principal investigator Dr. Kelly McNagny, Professor, Faculty of Medicine, Department of Medical Genetics.

Dr. Kelly McNagny Video ...http://protokinetix.com/videos/
Dr. Kelly McNagny Bio